INSIGHTS ON LIQUID DOSE MANUFACTURING

LIQUID DOSE MANUFACTURING SOLUTIONS

  • The Echo 525 Acoustic Liquid Handler features a rapid acoustic liquid handling design specifically for biochemical and genomic reagent transfer, highly precise and accurate low volume transfers enabling assay miniaturization, and a suite of Echo Software Applications guide creation of complex protocols.

  • Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.

  • Pharmaceutical companies, researchers, scientists, and medical professionals work tirelessly to create and bring crucial vaccines and immunizations to the market. Understanding key product characterization details such as sterilization, secure packaging and optimal process conditions for manufacturing are necessary elements of the vaccine development process. The right vaccine development machines and filling equipment minimize obstacles to gaining this poduct and process knowledge. To aid the vaccine development process, AST’s vaccine filling machine, GENiSYS®C allows scientists and pharmaceutical companies to differentiate their vaccine product and develop data-driven manufacturing processes in more meaningful and scalable ways.

  • AST aseptic filling products address the unique processing requirements of biologics manufacturing to gently care for biologic products during the fill-finish process. Their highly accurate peristaltic dosing system uses single-use pharmaceutical grade tubing that has been optimized to keep shear stress to an absolute minimum. When exiting the fluid path through the filling needle, the motion control system maintains the fill needle within the container and slowly rises as the product is being dispensed to minimize splashing and foaming that could introduce stress to the product. Temperature controlled filling is also possible with the ASEPTiCell® and GENiSYS® systems. AST has experience dosing products at temperatures as low as 3°C.

  • Modernize oligonucleotide manufacturing with robust filtration systems built for hazardous environments. Enhance purity and speed across every batch to ensure reliable and scalable production.